Overview

A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients

Status:
Completed
Trial end date:
2017-11-28
Target enrollment:
Participant gender:
Summary
This is a multicentre, open-label, one-arm Phase II extension study to evaluate the safety and tolerability of MIV-711 in patients with knee joint osteoarthritis (OA).
Phase:
Phase 2
Details
Lead Sponsor:
Medivir